Polski Lek S.A.
FDA import alert and refusal historyWadowice, PolandFEI 3008924214
As of October 26, 2026, Polski Lek S.A. is not on any FDA import alert in SupplierRadar's records; FDA refused 4 of its shipment lines between October 2, 2020 and July 25, 2022, most often for required label information not in english (NO ENGLISH).
Data from FDA public records, last checked . Request a correction
Current status
- Import alerts
- Not listed
- Last import refusal
- Herbals & botanicals (not teas), n.e.c. · NO ENGLISH
- Last warning letter
- None found
- Last inspection
- None on record
Every FDA record for Polski Lek S.A.
4 records, newest first. Each line links to the FDA page it came from.
2022
- Import refusalRefused, Herbals & botanicals (not teas), n.e.c.NO ENGLISHNUTRIT LBLEntry 274-0278027-7Source
- Import refusalRefused, Vitamin, mineral, proteins and unconventional dietary specialities for humans and animals, n.e.c.NO ENGLISHEntry 799-6947401-3Source
- Import refusalRefused, Vitamin, mineral, proteins and unconventional dietary specialities for humans and animals, n.e.c.NO ENGLISHEntry 799-6309859-4Source
2020
- Import refusalRefused, Vitamin, mineral, proteins and unconventional dietary specialities for humans and animals, n.e.c.LIST INGREDIETARYINGNCONTACTLABELINGNUTRIT LBLEntry 799-8854681-6Source
Refusal charges, in plain English
- NO ENGLISH3 refused lines
Required label information not in English
Information that must appear on the label appeared not to be given in English, or not to be repeated in every language used on the label.
- NUTRIT LBL2 refused lines
Nutrition information missing from label
The label or labeling appeared not to carry the nutrition information that U.S. law requires for the food.
- DIETARYING1 refused line
Dietary ingredients not listed
The dietary supplement label appeared not to list each dietary ingredient and its quantity, or the total quantity of a proprietary blend.
- LABELING1 refused line
Fair Packaging and Labeling Act
The package appeared not to meet the Fair Packaging and Labeling Act because of the placement, form, or contents of a required label statement.
- LIST INGRE1 refused line
Ingredients not listed
The product is made from two or more ingredients and the label appeared not to list the common or usual name of each one (or, for a juice beverage, the percentage of juice).
- NCONTACT1 refused line
No U.S. adverse event contact on supplement label
The dietary supplement label appeared not to show a U.S. address or phone number through which a serious adverse event can be reported.
Questions about Polski Lek S.A.
- Is Polski Lek S.A. on an FDA import alert?
- No listing for Polski Lek S.A. appears in the FDA import alerts SupplierRadar checked on October 26, 2026. Country-wide alerts may still apply to its products; see the Poland page.
- Has FDA refused shipments from Polski Lek S.A.?
- Yes. FDA refused 4 shipment lines from Polski Lek S.A. between October 2, 2020 and July 25, 2022. The most recent, on July 25, 2022, was herbals & botanicals (not teas), n.e.c., charged as NO ENGLISH (required label information not in english).
- Why did FDA refuse Polski Lek S.A.'s shipments?
- The most frequent charges are NO ENGLISH (required label information not in english, 3 lines) and NUTRIT LBL (nutrition information missing from label, 2 lines).
- What is Polski Lek S.A.'s FEI number?
- Polski Lek S.A.'s FDA Establishment Identifier (FEI) is 3008924214.
Buying from Polski Lek S.A.?
Watch it and get the FDA record the day it changes. Free for one supplier.
SupplierRadar is not affiliated with the U.S. Food and Drug Administration. Data comes from public FDA records and may contain errors. This is not legal advice; importers remain responsible for their supplier evaluations.